Physician profile
Robert T Terry
NPI 1588669071
$12,026.45
in general payments reported to CMS, 2019-2025
14 companies · $2,349 in 2025
The $2,349 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,171 · 2020: $862 · 2021: $680 · 2022: $703 · 2023: $2,796 · 2024: $465 · 2025: $2,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,161 · Food and Beverage: $2,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,160.92 |
| Food and Beverage | $2,449.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,421.09 | 2019-2025 | Triclip, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $2,444.99 | 2021-2025 | Micra, Selectsecure, Azure Xt Dr Mri Surescan |
| Medtronic Vascular, INC. | $2,125.08 | 2019 | |
| Edwards Lifesciences Corporation | $1,631.45 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $897.48 | 2020-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Novartis Pharmaceuticals Corporation | $156.91 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $133.33 | 2019-2023 | Xarelto |
| Pfizer INC. | $60.47 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $49.37 | 2022-2023 | Eliquis |
| Chiesi USA, INC. | $34.36 | 2019 | |
| Stryker Corporation | $22.44 | 2021 | |
| Asahi Intecc USA, INC. | $19.44 | 2022 | |
| Biosense Webster, INC. | $16.46 | 2024 | Na, Carto 3, Soundstar |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Terry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.